cancer-vaccine
2 stories tagged "cancer-vaccine"
Investigations
The Last Time Moderna's Stock Soared on Vaccine News, Insiders Sold $400 Million. It's Happening Again.
Moderna's stock has run up 137 percent in a month on a melanoma-vaccine trial that has not released its detailed data or reported overall survival. As retail chased the rally, the CEO sold $28.7 million in shares two weeks before the readout, and the rest of the C-suite cashed out after the stock tr
CancerTwenty People, No Control Arm, and a Startup on the Side: Reading the Pancreatic Cancer Vaccine's Fine Print
Ninety percent of twenty volunteers made KRAS-specific T cells. None was shown to avoid cancer. Two of the investigators co-founded the company that licensed the shot from Johns Hopkins, which stands to collect royalties.